Clinical immunology/allergy specialist,
Auckland City Hospital
Auckland,
New Zealand
Honorary. Associate Professor Hilary Longhurst
Senior Medical Officer in Immunology at Te Toka Tumai | Auckland City Hospital & Honorary Associate Professor at the University of Auckland, New Zealand.
Assoc. Prof Hilary Longhurst qualified in medicine from Cambridge University and Imperial College, London.
She developed her interest in Immunology while studying for her PhD at the National Institute for Medical Research (now the Crick Institute).
She worked as a Clinical and Laboratory Immunologist in London for many years, before relocating to New Zealand in 2020.
Hilary has been instrumental in developing patient-centred services for those with primary immune deficiency, including and hereditary angioedema due to C1 inhibitor deficiency and serves on international HAE guideline committees. Her clinic was one of the first to promote home immunoglobulin and C1 inhibitor replacement.
Being involved in most major HAE and several immunoglobulin trials in the past 20 years, she has been a pioneer in developing and enabling access to the new therapies, which have transformed the lives of people with this disabling disorder.
She serves on the Rare Disorders NZ (RDNZ) clinical committee, was a founding medical advisor with UKPIPS (supporting antibody deficient patients), HAE UK (supporting angioedema patients) and DCAction (supporting families affected by genetic telomere biology disorders). She serves on steering committees for many educational and academic events.
She received the Milton Gold Memorial Lectureship Award from the Canadian Society of Allergy and Clinical Immunology in 2020. She became an honorary life member of the Hereditary Angioedema Society of India, with establishment of the Hilary Longhurst annual lecture in 2021
Hilary has published over 200 academic papers in the field of immune deficiency and angioedema.